Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.825 USD | -4.85% | +2.14% | -23.34% |
May. 08 | Transcript : PDS Biotechnology Corporation - Special Call | |
May. 02 | PDS Biotechnology Corporation Appoints Stephan Toutain as Chief Operating Officer | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 275K | Capitalization | 147M |
---|---|---|---|---|---|
Net income 2024 * | -51M | Net income 2025 * | -63M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 536 x |
P/E ratio 2024 * |
-2.66
x | P/E ratio 2025 * |
-2.53
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.99% |
Latest transcript on PDS Biotechnology Corporation
1 day | -4.85% | ||
1 week | +2.14% | ||
Current month | +13.73% | ||
1 month | +16.51% | ||
3 months | -28.45% | ||
6 months | -22.40% | ||
Current year | -23.34% |
Managers | Title | Age | Since |
---|---|---|---|
Frank Bedu-Addo
FOU | Founder | 59 | 19-03-14 |
Director of Finance/CFO | 55 | Dec. 03 | |
David Schaaf
CTO | Chief Tech/Sci/R&D Officer | - | 22-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Glover
CHM | Chairman | 60 | 19-04-01 |
Otis Brawley
BRD | Director/Board Member | 64 | 20-11-02 |
Richard Sykes
BRD | Director/Board Member | 79 | 19-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +3.43% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 3.825 | -4.85% | 946 237 |
24-05-08 | 4.02 | +6.49% | 1,844,914 |
24-05-07 | 3.775 | +1.21% | 616,235 |
24-05-06 | 3.73 | -2.36% | 775,623 |
24-05-03 | 3.82 | +2.41% | 430,970 |
Delayed Quote Nasdaq, May 09, 2024 at 03:44 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.34% | 147M | |
+3.17% | 108B | |
+10.37% | 105B | |
+1.57% | 23.46B | |
-13.18% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-7.20% | 17.19B | |
+5.84% | 13.99B | |
+36.35% | 12.53B |
- Stock Market
- Equities
- PDSB Stock